Success Metrics

Clinical Success Rate
57.1%

Based on 4 completed trials

Completion Rate
57%(4/7)
Active Trials
1(9%)
Results Posted
50%(2 trials)
Terminated
3(27%)

Phase Distribution

Ph phase_2
1
9%
Ph phase_4
1
9%
Ph not_applicable
7
64%

Phase Distribution

0

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution9 total trials
Phase 2Efficacy & side effects
1(11.1%)
Phase 4Post-market surveillance
1(11.1%)
N/ANon-phased studies
7(77.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

50.0%

4 of 8 finished

Non-Completion Rate

50.0%

4 ended early

Currently Active

1

trials recruiting

Total Trials

11

all time

Status Distribution
Active(2)
Completed(4)
Terminated(4)
Other(1)

Detailed Status

Completed4
Terminated3
Recruiting1
Not yet recruiting1
unknown1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
1
Success Rate
57.1%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (11.1%)
Phase 41 (11.1%)
N/A7 (77.8%)

Trials by Status

recruiting19%
not_yet_recruiting19%
unknown19%
terminated327%
completed436%
withdrawn19%

Recent Activity

1 active trials
Showing 5 of 11
recruitingnot_applicable

PRE-EMPTIVE PHARMACOGENOMICS IN ACUTE CARE SETTINGS WITH HEALTH ECONOMIC EVALUATIONS (PHOENIX TRIAL)

NCT06907784
not_yet_recruitingnot_applicable

Pharmacogenomic Testing in Pediatric Hematology/Oncology Patients

NCT06744712
completednot_applicable

PREemptive Pharmacogenomic Testing for Preventing Adverse Drug REactions

NCT03093818
completednot_applicable

A Single-center Randomized Controlled Study on the Effect of Pharmacogenomics Trial on Clinical Efficacy in Patients With Depression

NCT05959187
withdrawn

Implementation of a Pharmacist-led Pharmacogenomic Clinical Service

NCT04984538
View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials
NCT06907784Not Applicable

PRE-EMPTIVE PHARMACOGENOMICS IN ACUTE CARE SETTINGS WITH HEALTH ECONOMIC EVALUATIONS (PHOENIX TRIAL)

Recruiting
NCT06744712Not Applicable

Pharmacogenomic Testing in Pediatric Hematology/Oncology Patients

Not Yet Recruiting
NCT03093818Not Applicable

PREemptive Pharmacogenomic Testing for Preventing Adverse Drug REactions

Completed
NCT05959187Not Applicable

A Single-center Randomized Controlled Study on the Effect of Pharmacogenomics Trial on Clinical Efficacy in Patients With Depression

Completed
NCT04984538

Implementation of a Pharmacist-led Pharmacogenomic Clinical Service

Withdrawn
NCT02542397Phase 2

LCI-NOS-PAIN-001: A Prospective, Pharmacogenomic-Driven Study of Pain Management in Oncology Outpatients

Terminated
NCT03228953Not Applicable

Pharmacogenomic Testing in Major Depressive Disorder

Terminated
NCT05053815

Pharmacogenomic Testing in a Program of All-inclusive Care for the Elderly (PACE) Setting

Unknown
NCT02932579Phase 4

Utility of Pharmacogenomic Testing and Postoperative Dental Pain Outcomes

Terminated
NCT03803293Not Applicable

Right Drug, Right Dose, Right Time - Using Genomic Data to Individualize Treatment

Completed
NCT03591224Not Applicable

Pharmacogenomic Testing to Optimize Antidepressant Drug Therapy

Completed

All 11 trials loaded

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
11